Pharma Dynamics (Pty) Ltd

pharmadynamics.co.za

Pharma Dynamics is the country’s leader in cardiovascular medication since 2012 - both in terms of value and volume – and is the fastest growing generic pharmaceutical company in South Africa. The organisation celebrates 16 years of improving the quality of life for South Africans after entrenching its mark in the industry with the launch of Amloc and Bilocor – SA’s two top selling anti-hypertensives. Today, Pharma Dynamics is active in more than 27 therapeutic areas, which include Central Nervous System (CNS), Female Healthcare, antimicrobial, pain and GIT categories, and it also supplies a range of Over the Counter (OTC) products.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BUSINESS INSIGHTS, PHARMACY MARKET

SHIELDS HEALTH SOLUTIONS AND NEMOURS CHILDREN’S HEALTH, DELAWARE PARTNER TO ENHANCE SPECIALTY PHARMACY SERVICES FOR PEDIATRIC CARE

Shields Health Solutions | March 17, 2023

news image

Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, announced that it has partnered with Nemours Children’s Health, Delaware, to collaborate in developing a specialty pharmacy program that will provide patients with complex, chronic conditions access to specialized pharmacy services designed to lower costs, expand treatment options, enhance medication management, and improve overall health. Shields will provide Nemours Children&rs...

Read More

BUSINESS INSIGHTS

OPTEL ACQUIRES PHARMA TRACK-AND-TRACE UNIT OF KÖRBER

OPTEL Group | January 12, 2022

news image

OPTEL GROUP, already a world leader in supply chain traceability, is expanding its expertise and global reach with the recent acquisition of the track-and-trace unit of the Körber Business Area Pharma, formerly known as Traxeed, based in Germany. Körber is a leading international technology group. The acquisition, announced today, will allow OPTEL to leverage the unit's expertise in pharmaceutical and agrochemical track-and-trace technologies, provide the company wit...

Read More

PHARMACY MARKET

XERIS BIOPHARMA ANNOUNCES RESEARCH EVALUATION COLLABORATION AND OPTION AGREEMENT WITH REGENERON FOR XERIJECT™

businesswire | April 03, 2023

news image

Xeris Biopharma Holdings, Inc. a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapeutic areas, today announced that it has entered into a platform research evaluation collaboration and option agreement with Regeneron Pharmaceuticals, Inc. Under the terms of the agreement, Xeris will use its proprietary drug-formulation platform, XeriJect™, to develop ultra-highly concentrated, ...

Read More

PRACTICE MANAGEMENT

ASCENTAGE PHARMA PRESENTS UPDATES ON ITS GLOBAL CLINICAL DEVELOPMENT AT THE J.P. MORGAN 39TH ANNUAL HEALTHCARE CONFERENCE

Ascentage Pharma | January 14, 2021

news image

Ascentage Pharma, an around the world engaged, clinical-stage biotechnology organization occupied with creating novel treatments for malignant growths, persistent hepatitis B (CHB), and age-related illnesses, introduced at the J.P. Morgan 39th Annual Healthcare Conference (a virtual occasion) at night of January 13, Beijing Time. During the introduction, Dr. Dajun Yang, Chairman and CEO of Ascentage Pharma, furnished business refreshes with an attention on the organization's worldwide R&...

Read More
news image

BUSINESS INSIGHTS, PHARMACY MARKET

SHIELDS HEALTH SOLUTIONS AND NEMOURS CHILDREN’S HEALTH, DELAWARE PARTNER TO ENHANCE SPECIALTY PHARMACY SERVICES FOR PEDIATRIC CARE

Shields Health Solutions | March 17, 2023

Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, announced that it has partnered with Nemours Children’s Health, Delaware, to collaborate in developing a specialty pharmacy program that will provide patients with complex, chronic conditions access to specialized pharmacy services designed to lower costs, expand treatment options, enhance medication management, and improve overall health. Shields will provide Nemours Children&rs...

Read More
news image

BUSINESS INSIGHTS

OPTEL ACQUIRES PHARMA TRACK-AND-TRACE UNIT OF KÖRBER

OPTEL Group | January 12, 2022

OPTEL GROUP, already a world leader in supply chain traceability, is expanding its expertise and global reach with the recent acquisition of the track-and-trace unit of the Körber Business Area Pharma, formerly known as Traxeed, based in Germany. Körber is a leading international technology group. The acquisition, announced today, will allow OPTEL to leverage the unit's expertise in pharmaceutical and agrochemical track-and-trace technologies, provide the company wit...

Read More
news image

PHARMACY MARKET

XERIS BIOPHARMA ANNOUNCES RESEARCH EVALUATION COLLABORATION AND OPTION AGREEMENT WITH REGENERON FOR XERIJECT™

businesswire | April 03, 2023

Xeris Biopharma Holdings, Inc. a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapeutic areas, today announced that it has entered into a platform research evaluation collaboration and option agreement with Regeneron Pharmaceuticals, Inc. Under the terms of the agreement, Xeris will use its proprietary drug-formulation platform, XeriJect™, to develop ultra-highly concentrated, ...

Read More
news image

PRACTICE MANAGEMENT

ASCENTAGE PHARMA PRESENTS UPDATES ON ITS GLOBAL CLINICAL DEVELOPMENT AT THE J.P. MORGAN 39TH ANNUAL HEALTHCARE CONFERENCE

Ascentage Pharma | January 14, 2021

Ascentage Pharma, an around the world engaged, clinical-stage biotechnology organization occupied with creating novel treatments for malignant growths, persistent hepatitis B (CHB), and age-related illnesses, introduced at the J.P. Morgan 39th Annual Healthcare Conference (a virtual occasion) at night of January 13, Beijing Time. During the introduction, Dr. Dajun Yang, Chairman and CEO of Ascentage Pharma, furnished business refreshes with an attention on the organization's worldwide R&...

Read More